Presentation is loading. Please wait.

Presentation is loading. Please wait.

Long-term efficacy and safety of once-daily enoxaparin plus warfarin for the outpatient ambulatory treatment of lower-limb deep vein thrombosis in the.

Similar presentations


Presentation on theme: "Long-term efficacy and safety of once-daily enoxaparin plus warfarin for the outpatient ambulatory treatment of lower-limb deep vein thrombosis in the."— Presentation transcript:

1 Long-term efficacy and safety of once-daily enoxaparin plus warfarin for the outpatient ambulatory treatment of lower-limb deep vein thrombosis in the TROMBOTEK trial  Mehmet Kurtoglu, MD, Cuneyt Koksoy, MD, Ekim Hasan, MD, Yigit Akcalı, MD, Ozalp Karabay, MD, Ugur Filizcan, MD  Journal of Vascular Surgery  Volume 52, Issue 5, Pages (November 2010) DOI: /j.jvs Copyright © 2010 Society for Vascular Surgery Terms and Conditions

2 Fig 1 Study plan according to seven consecutive visits within 18 months. CBC, Complete blood count; CT, computed tomography; INR, international normalized ratio; PT, prothrombin time; VTE, venous thromboembolism. Journal of Vascular Surgery  , DOI: ( /j.jvs ) Copyright © 2010 Society for Vascular Surgery Terms and Conditions

3 Fig 2 Complete recanalization ratios for iliofemoral (n = 67), external iliac (n = 33), common femoral (n = 61), femoral (n = 51), and popliteal veins (n = 29) specific to 3, 12, and 18 months of follow-up. *P < .001 compared with scores obtained at the previous visit. Journal of Vascular Surgery  , DOI: ( /j.jvs ) Copyright © 2010 Society for Vascular Surgery Terms and Conditions

4 Fig 3 Evaluation of symptom incidence (%) of patients for pain, edema, and tenderness during the course of the treatment. *P < .05 and **P < .001 compared with incidence at the previous visit. +P < .001 compared with pretreatment incidence. Journal of Vascular Surgery  , DOI: ( /j.jvs ) Copyright © 2010 Society for Vascular Surgery Terms and Conditions

5 Fig 4 Comparison of pretreatment and posttreatment period in terms of average difference in leg circumference (cm) of normal and diseased leg measured at the calf (below the tibial tuberosity) and at the middle thigh regions. *P < .05, **P < .01, and ***P < .001 compared with scores obtained at the previous visit. +P < .001 compared with pretreatment scores. Journal of Vascular Surgery  , DOI: ( /j.jvs ) Copyright © 2010 Society for Vascular Surgery Terms and Conditions

6 Fig 5 Percentage of patients with subtherapeutic international normalized ratio (INR) ≤2 or ≥3 with respect to the first 90 days. Journal of Vascular Surgery  , DOI: ( /j.jvs ) Copyright © 2010 Society for Vascular Surgery Terms and Conditions


Download ppt "Long-term efficacy and safety of once-daily enoxaparin plus warfarin for the outpatient ambulatory treatment of lower-limb deep vein thrombosis in the."

Similar presentations


Ads by Google